Pfizer said late Tuesday that it plans to cut 20% of its U.S. sales force as the first step in the comprehensive review of operations announced last month by the world's largest pharmaceutical maker.
New York-based Pfizer said it will disclose additional actions, and its long-term outlook, in January.
"The changes we are making today will better align our sales organization to our overall customer and business needs," Chief Executive Jeffrey Kindler said in a company statement.
"This is an important step toward making Pfizer a more agile and effective company."
More
Insider's view: the timing is "interesting" to say the least.
Just in time for Christmas. But before the pipeline review with Wall Street on Thursday.
Now we understand what all those "sacred cow" comments referred to!
New York-based Pfizer said it will disclose additional actions, and its long-term outlook, in January.
"The changes we are making today will better align our sales organization to our overall customer and business needs," Chief Executive Jeffrey Kindler said in a company statement.
"This is an important step toward making Pfizer a more agile and effective company."
More
Insider's view: the timing is "interesting" to say the least.
Just in time for Christmas. But before the pipeline review with Wall Street on Thursday.
Now we understand what all those "sacred cow" comments referred to!
3 comments:
Reduction of 20% in sales force. What is that in terms of number of sales forces? Two? It is well known in the big pharma biz, but not by the public, that all the big ones have used multiple sales forces, to sell the same product(s) to the same target customers. That means, your GP would be seen by 6-8 sales reps on very frequent basis, perhaps every week or so by Pfizer GP sales rep. selling him/her Viagra or Norvasc for instance, over and over again. Every rep in every GP sales force sells the same drugs to the same doctor, at all time. No other business on this Planet does this. Employing up to 10 sales reps to sell the same product to the very same customer. This was a big pharma invention and they all do it. Perhaps Pfizer started and now they started the reversal of the trend. Most likely for many reasons, like doctors were getting sick of being sold the same product over and over again by multiple sales reps, the cost of such deployement must be astronomical etc. Also it must be morally unaceptible, having all these reps waisting doctors' valuable time with thier same sales message over and over again.
This was one more example of big pharma going too far and getting away with it while making enormous profits.How sweet it is!
ps. just watch the other big pharma companies do the same thing very soon. Time to update those CV's.
Keep the pretty ones, sack the ugly ones
You must be a doctor or the ugly one close to retirement. That would relly be a sweet deal for you. Wait it just might happen to you. Good luck.
If you are a doctor, the good times in big pharma are coming to an end and so are the "benefits" to you, grab while you can.
Post a Comment